These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 19604112

  • 1. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D, Kurt E, Kurt H, Degirmenci I, Kuçukarabaci B, Metintas M, Kucuk MU, Gunes HV, Colak E.
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C, Bayram B, Ozkurt M, Onlu H, Erkasap N, Mutlu F.
    Genet Test Mol Biomarkers; 2011 Aug; 15(7-8):565-7. PubMed ID: 21413876
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.
    Gunes HV, Cosan DT, Ata N, Birdane A, Ustuner MC, Dikmen M, Bayram B, Degirmenci I.
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):303-5. PubMed ID: 20392162
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY, Ataç FB, Ogus E, Ozbek N.
    Allergy Asthma Proc; 2009 Jun; 30(1):41-6. PubMed ID: 19063817
    [Abstract] [Full Text] [Related]

  • 5. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
    Bayram B, Sayin E, Erkasap N, Onlü H, Ozkurt M, Sahin F, Türkoğlu Z.
    Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
    [Abstract] [Full Text] [Related]

  • 6. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 7. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 8. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Guler HI, Ustuner C, Musmul A.
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E, Soylar R, Arıkan-Ayyıldız Z, Uzuner N, Giray-Bozkaya Ö, Erçal D, Karaman Ö, Ülgenalp A.
    Allergol Immunopathol (Madr); 2013 Aug; 41(1):11-6. PubMed ID: 22361338
    [Abstract] [Full Text] [Related]

  • 11. Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.
    Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, Donati MB, Iacoviello L.
    J Investig Allergol Clin Immunol; 2008 Aug; 18(4):284-92. PubMed ID: 18714537
    [Abstract] [Full Text] [Related]

  • 12. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [Abstract] [Full Text] [Related]

  • 13. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome.
    Luo Y, Wang C, Tu H.
    Mol Med Rep; 2014 Mar; 9(3):894-8. PubMed ID: 24435552
    [Abstract] [Full Text] [Related]

  • 14. Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke.
    Kucukarabaci B, Gunes HV, Ozdemir G, Cosan D, Ozbabalik D, Dikmen M, Degirmenci I.
    Genet Test; 2008 Sep; 12(3):443-51. PubMed ID: 18662099
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D, Yurdakök M, Okur H, Gürgey A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [Abstract] [Full Text] [Related]

  • 16. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.
    Lampalo M, Jukic I, Bingulac-Popovic J, Marunica I, Petlevski R, Pavlisa G, Popovic-Grle S.
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374
    [Abstract] [Full Text] [Related]

  • 17. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Jun; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 18. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L.
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [Abstract] [Full Text] [Related]

  • 19. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.
    Akar N, Yilmaz E, Akar E, Avcu F, Yalçin A, Cin S.
    Thromb Res; 2000 Feb 15; 97(4):227-30. PubMed ID: 10674409
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Feb 15; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.